One in four older US veterans report being diagnosed with cardiovascular disease in their lifetime, according to study findings.

About 8 in 10 infants received respiratory syncytial virus protection during the 2023 to 2024 season, according to study findings.

Coffee drinking timing is associated with all-cause and cardiovascular disease-specific mortality risk, according to study findings.

Doxycycline postexposure prophylaxis initiation is associated with decreases in sexually transmitted infections.

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.